“3 “Strong Buy” Healthcare Stocks Under $5 That Could Go Boom”
October 2, 2020
“Kintara Therapeutics (KTRA)…
Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the word on the Street is that KTRA is a Strong Buy. Given the $4.33 average price target, shares could soar 218% from current levels…
DiaMedica Therapeutics (DMAC)…
Overall, DMAC shares get a unanimous thumbs up from the analyst consensus, with 3 recent Buy reviews adding up to a Strong Buy rating. At $14.33, the average price target implies 248% upside potential from current levels…
OPKO Health (OPK)…
All in all, other analysts echo Tenthoff’s sentiment. 4 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $8, the upside potential comes in at 107%…”
https://finance.yahoo.com/news/3-strong-buy-healthcare-stocks-193054154.html